MENU
RPTX
AS OF
Nov 21, 04:59 PM (EDT)
Price
$2.13
Change
+$0.03 (+1.43%)
Capitalization
91.56M
101 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Repare Therapeutics (RPTX) Earnings Date & Reports

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

A.I. Advisor
published Earnings

RPTX is expected to report earnings to fall 424.50% to -25 cents per share on March 03

Repare Therapeutics RPTX Stock Earnings Reports
Q4'25
Est.
$-0.26
Q3'25
Beat
by $0.57
Q2'25
Beat
by $0.17
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.14
The last earnings report on November 14 showed earnings per share of 7 cents, beating the estimate of -49 cents. With 1.17M shares outstanding, the current market capitalization sits at 91.56M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RPTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RPTX showed earnings on November 14, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RPTX
A.I. Advisor
published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com